Saudi Aramco Promises Full Output Return If Hormuz Opens
Saudi Aramco signals it could restore full output within days if Hormuz reopens, a development that investors are wat...
Ways To Make Extra Money While In Debt
Making extra money while in debt can ease financial pressure. Discover practical ways to increase your income and reduce debt.
27,828 articles
This Billionaire Tesla Bull Bets Big on Nvidia Stock
A major stake in Nvidia from a notable Tesla bull underscores confidence in the AI chip leader’s growth trajectory, e...
Flying Taxis Could Soon Take Flight Across 26 States
The FAA unveiled an eight-project pilot program to test electric takeoff-and-landing aircraft in 26 states, signaling...
Coherent Says NVIDIA Supply Stretches to 2030 on Multibillion Deal
Coherent finalizes a multibillion-dollar, long-term supply agreement with NVIDIA through 2030, fueling AI infrastruct...
Futures Down Nearly Points as Oil Prices Climb Again
Oil prices extend gains, pushing Dow futures lower as traders brace for inflation data and central-bank signals. Vola...
After Run, Climb Another: Can CSX Reach $46 Target Ahead?
CSX stock has surged, but a move to Bank of America’s $46 target hinges on margin expansion and a steadier freight ma...
Bitcoin Set for Rip to $80,000 Even Prices Amid Oil Surge
Bitcoin steadies near the $70,000 mark as oil prices leap and geopolitical tensions rise. Analysts weigh whether the ...
Three Overlooked U.S. Value Stocks Poised to Outperform 2026
A trio of overlooked U.S. value stocks combines strong balance sheets with cheap earnings multiples, making them cand...
Clarity Faces Slim Odds in 2026 as Crypto Legislation Stalls
Galaxy Digital warns the CLARITY Act may stall in 2026 without a timely committee vote, with lawmakers juggling other...
Aging Yet Reliable: Weapons the U.S. Still Uses Today
As 2026 unfolds, a significant portion of the U.S. arsenal remains built on aging yet upgraded weapons that continue ...
Biotech Stock Nearly 300% Sparks Massive Bet on 2027 Breast Drug
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status